CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Palliative cancer care - nausea & vomiting - Management
Haloperidol (oral or parenteral)
Age from 16 years onwards
Haloperidol tablets: 1.5mg at night and when required
Haloperidol 1.5mg tablets
Take one tablet at night AND when required to relieve nausea and vomiting.
Supply 14 tablets.
Haloperidol tablets: 1.5mg twice a day and when required
Haloperidol 1.5mg tablets
Take one tablet twice a day AND when required to relieve nausea and vomiting.
Supply 21 tablets.
Haloperidol tablets: 3mg twice a day and 1.5mg when required
Haloperidol 1.5mg tablets
Take two tablets twice a day AND take one tablet when required to relieve nausea and vomiting.
Supply 28 tablets.
Haloperidol tablets: 5mg twice a day
Haloperidol 5mg tablets
Take one tablet twice a day.
Supply 14 tablets.
Haloperidol subcutaneous inj: 1mg to 2.5mg when required
Haloperidol 5mg/1ml solution for injection ampoules
FOR SUBCUTANEOUS INJECTION. Give 0.2ml (1mg) to 0.5ml (2.5mg) by subcutaneous injection when required to relieve nausea and vomiting.
Supply 5 1ml ampoules.
Haloperidol subcutaneous infusion: 2.5mg-10mg over 24 hours
Haloperidol 5mg/1ml solution for injection ampoules
FOR CONTINUOUS SUBCUTANEOUS INFUSION. Give 0.5ml (2.5mg) to 2ml (10mg) over 24 hours via a syringe driver.
Supply 6 1ml ampoules.
© NHS Institute for Innovation and Improvement